Management of the stone former.
D000493:Allopurinol / Q000627:therapeutic use; D002118:Calcium / Q000652:urine; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D003555:Cystinuria / Q000628:therapy; D004032:Diet / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007669:Kidney Calculi / Q000188:drug therapy / Q000628:therapy / Q000652:urine; D008274:Magnesium / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use / Q000652:urine; D014527:Uric Acid / Q000652:urine; D014545:Urinary Calculi / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000628:therapy*
D010710:Phosphates; D006852:Hydrochlorothiazide; D014527:Uric Acid; D000493:Allopurinol; D002482:Cellulose; C008881:phosphocellulose; D008274:Magnesium; D002118:Calcium